These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 7679154

  • 1. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F, Weissenburger J, Guhennec C, Jagueux M, Davy JM, Vernhet L, Simandoux V, Poirier JM, Cheymol G.
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [Abstract] [Full Text] [Related]

  • 2. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
    Chézalviel-Guilbert F, Davy JM, Poirier JM, Weissenburger J.
    J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiological mechanisms of action of the levorotatory isomer of sotalol in a canine infarct model of inducible ventricular tachycardia: comparison with the beta-1 receptor antagonist bisoprolol.
    Aidonidis I, Rizos I, Hilbel T, Kuebler W, Brachmann J.
    J Mol Cell Cardiol; 1994 Jul; 26(7):841-8. PubMed ID: 7966352
    [Abstract] [Full Text] [Related]

  • 4. Combination of antiarrhythmic drugs.
    Lüderitz B, Mletzko R, Jung W, Manz M.
    J Cardiovasc Pharmacol; 1991 Jul; 17 Suppl 6():S48-52. PubMed ID: 1723119
    [Abstract] [Full Text] [Related]

  • 5. [Action of sotalol on high-amplification electrocardiogram].
    Brembilla-Perrot B, Houriez P, Preiss JP, Claudon O, Beurrier D, Terrier de la Chaise A, Louis P.
    Arch Mal Coeur Vaiss; 2000 Mar; 93(3):271-5. PubMed ID: 11004973
    [Abstract] [Full Text] [Related]

  • 6. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A, Gout B, Bonhomme M, Landais L, Faivre JF, Linee P, Poyser RH, Ruffolo RR.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [Abstract] [Full Text] [Related]

  • 7. The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. II. Effects on action potential duration and refractoriness.
    Berman ND, Wang LY, Ahmed A.
    Can J Cardiol; 1990 Nov; 6(9):423-30. PubMed ID: 2177360
    [Abstract] [Full Text] [Related]

  • 8. Preferential action of mexiletine on central common pathway of reentrant ventricular tachycardia.
    Aizawa Y, Abe A, Ohira K, Furushima H, Chinushi M, Fujita S.
    J Am Coll Cardiol; 1996 Dec; 28(7):1759-64. PubMed ID: 8962563
    [Abstract] [Full Text] [Related]

  • 9. Does mexiletine have a preferential action (versus healthy myocardium) on the reentrant circuit of ventricular tachycardia?
    Abe A, Aizawa Y, Ma M.
    Heart Vessels; 1997 Dec; Suppl 12():235-9. PubMed ID: 9476592
    [Abstract] [Full Text] [Related]

  • 10. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
    Aidonidis I, Poyatzi A, Stamatiou G, Lymberi M, Stamatoyannis N, Molyvdas PA.
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
    [Abstract] [Full Text] [Related]

  • 11. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L, Cui G, Sakaguchi Y, Singh BN.
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [Abstract] [Full Text] [Related]

  • 12. Beta receptor blockade potentiates the antiarrhythmic actions of d-sotalol on reentrant ventricular tachycardia in a canine model of myocardial infarction.
    Kassotis J, Sauberman RB, Cabo C, Wit AL, Coromilas J.
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1233-44. PubMed ID: 14678141
    [Abstract] [Full Text] [Related]

  • 13. Sotalol and mexiletine: combination of rate-dependent electrophysiological effects.
    Varró A, Lathrop DA.
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):557-67. PubMed ID: 1706796
    [Abstract] [Full Text] [Related]

  • 14. Proarrhythmia of a class Ic drug: suppression by combination with a drug prolonging repolarization in the dog late after infarction.
    Duff HJ, Stemler M, Thannhauser T, Laganiere S, Rude E, Lester W.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):508-15. PubMed ID: 7616438
    [Abstract] [Full Text] [Related]

  • 15. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T, Hashimoto K.
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [Abstract] [Full Text] [Related]

  • 16. Mechanism-specific antiarrhythmic effects of the potassium channel activator levcromakalim against repolarization-dependent tachycardias.
    Vos MA, Gorgels AP, Lipcsei GC, De Groot SH, Leunissen JD, Wellens HJ.
    J Cardiovasc Electrophysiol; 1994 Sep; 5(9):731-42. PubMed ID: 7827712
    [Abstract] [Full Text] [Related]

  • 17. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A.
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [Abstract] [Full Text] [Related]

  • 18. Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol.
    Lynch JJ, Wilber DJ, Montgomery DG, Hsieh TM, Patterson E, Lucchesi BR.
    J Cardiovasc Pharmacol; 1984 Oct; 6(6):1132-41. PubMed ID: 6084771
    [Abstract] [Full Text] [Related]

  • 19. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study.
    Gelzer AR, Kraus MS, Rishniw M, Hemsley SA, Moïse NS.
    J Vet Cardiol; 2010 Aug; 12(2):93-106. PubMed ID: 20663731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.